Ardelyx Inc to Discuss Launching IBSRELA Second Quarter of 2022 Call Transcript
Good morning, and welcome to Ardelyx's conference call. (Operator Instructions) Session after the prepared remarks. As a reminder, today's call is being recorded. I would now like to turn the call over to Justin Renz, Chief Financial Officer of Ardelyx. You may begin.
Thank you, and good morning, everyone. During this call, we will refer to the press release we issued earlier today, which is available in the Investors section of the company's website at ardelyx.com. On the call with me today are Mike Raab, President and CEO; and David Rosenbaum, our Chief Development Officer; Susan Rodriguez, our Chief Commercial Officer; and Dr. William Chey, Nostrant Professor of Medicine at the University of Michigan School of Medicine. A thought with Gastroenterologists, who will share some prepared remarks. Dr. Laura Williams, our Chief Medical Officer, will also join us for the question-and-answer period.
During this call, we will be making forward-looking statements that are subject to risks and uncertainties. Our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
